Article
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
2 Oct 2014
Abstract excerpt
BACKGROUND: The lastly identified claudin-low (CL) subtype of breast cancer (BC) remains poorly described as compared to the other molecular subtypes. We provide a comprehensive characterization of the largest series of CL samples reported so far. METHODS: From a data set of 5447 invasive BC profiled using DNA microarrays, we identified 673 CL samples (12,4%) that we describe comparatively to the other molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
